A full-term newborn presents with a fully formed, violaceous vascular lesion at birth. With imaging revealing mixed vascular flow and no postnatal proliferation, can you distinguish this rare entity from...
Richter transformation of chronic lymphocytic leukemia carries poor outcomes with traditional therapies, but emerging treatments may improve survival. Test your knowledge of prognosis by taking this quick...
In an interview with Consultant360, Junaid Anwar, MD, a hematology-oncology fellow at UT Health Houston, reviewed the current evidence base for JAK inhibitors in myelofibrosis from a pooled analysis of five...
The survival outcomes for patients diagnosed with this chronic lymphocytic leukemia complication have remained poor for decades. Can you name the complication? Take the quiz to find out!
Consultant360’s Photoclinic Challenge is an interactive quiz based on an image featured in a Photoclinic article. View the slideshow for a brief overview of the case, patient history, and a key hint. For...
A recent study on momelotinib's effectiveness in patients with myelofibrosis reveals key findings from the SIMPLIFY-1 and SIMPLIFY-2 trials. Can you identify the treatment's impact on symptom response? Test...
Risk factors may give a clinician an idea of the chance their patient has of developing a disease, like chronic lymphocytic leukemia (CLL). There are few known risk factors linked to CLL. Do you know which...
While most cases of chronic lymphocytic leukemia are appropriately managed with medication therapy, rare cases require the use of additional treatment modalities. Which of these other treatments have you...
